|
⚲
|
| Keyboard |
| McEnany Patrick J
✚
|
|
|---|---|
| CIK # | 0000929985 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0000929985] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| McEnany Patrick J | |
| Cesca Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Tax withheld | 6,786 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-29 | Option exercise | 26,334 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Option exercise | 26,334 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-08 | Option exercise | 3,534 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-08 | Option exercise | 3,534 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-01 | Gift | 45,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-01 | Gift | 45,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-01 | Gift | 45,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-21 | Option exercise | 1,775 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-21 | Option exercise | 1,775 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 34,921 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 10,540 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-06-09 | Sell | 171,748 | $26.11 | 4,484,340 |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-06-06 | Sell | 28,252 | $25.95 | 733,139 |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 3,533 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 3,533 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-11-21 | Grant | 5,327 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-11-21 | Grant | 43,591 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-11-20 | Option exercise | 72,500 | $3.54 | 256,650 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-11-20 | Option exercise | 72,500 | $0.00 | |
| showing 20 of 183 most recent transactions | |||||